Rapid Micro Biosystems Inc (RPID) - Total Assets
Based on the latest financial reports, Rapid Micro Biosystems Inc (RPID) holds total assets worth $58.45 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Rapid Micro Biosystems Inc - Total Assets Trend (2010–2025)
This chart illustrates how Rapid Micro Biosystems Inc's total assets have evolved over time, based on quarterly financial data. Also see how much is Rapid Micro Biosystems Inc worth for the company's overall valuation and market capitalisation.
Rapid Micro Biosystems Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Rapid Micro Biosystems Inc's total assets of $58.45 Million consist of 81.7% current assets and 18.3% non-current assets. Review RPID total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 26.8% |
| Accounts Receivable | $3.28 Million | 4.4% |
| Inventory | $17.59 Million | 23.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Rapid Micro Biosystems Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Rapid Micro Biosystems Inc (RPID) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Rapid Micro Biosystems Inc's current assets represent 81.7% of total assets in 2025, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 26.8% of total assets in 2025, up from 6.7% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 49.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 23.5% of total assets.
Rapid Micro Biosystems Inc Competitors by Total Assets
Key competitors of Rapid Micro Biosystems Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
SHE:300760
|
China | CN¥59.27 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
Brainsway Ltd
NASDAQ:BWAY
|
USA | $121.97 Million |
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
USA | $272.12 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
Rapid Micro Biosystems Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.55 | 3.67 | 13.78 |
| Quick Ratio | 1.51 | 2.41 | 12.98 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $28.11 Million | $43.74 Million | $226.44 Million |
Rapid Micro Biosystems Inc - Advanced Valuation Insights
This section examines the relationship between Rapid Micro Biosystems Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.46 |
| Latest Market Cap to Assets Ratio | 0.68 |
| Asset Growth Rate (YoY) | -23.8% |
| Total Assets | $74.85 Million |
| Market Capitalization | $50.68 Million USD |
Valuation Analysis
Below Book Valuation: The market values Rapid Micro Biosystems Inc's assets below their book value (0.68x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Rapid Micro Biosystems Inc's assets decreased by 23.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Rapid Micro Biosystems Inc (2010–2025)
The table below shows the annual total assets of Rapid Micro Biosystems Inc from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $74.85 Million | -23.75% |
| 2024-12-31 | $98.17 Million | -31.57% |
| 2023-12-31 | $143.45 Million | -24.76% |
| 2022-12-31 | $190.65 Million | -20.95% |
| 2021-12-31 | $241.17 Million | +244.54% |
| 2020-12-31 | $70.00 Million | +120.89% |
| 2019-12-31 | $31.69 Million | +1805.47% |
| 2011-12-31 | $1.66 Million | -28.29% |
| 2010-12-31 | $2.32 Million | -- |
About Rapid Micro Biosystems Inc
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, … Read more